Systemic sclerosis: therapy update and current studies

Your benefits at

  • Personalized content tailored to your profile
  • DFP advanced training: e-learning, literature studies & MM courses
  • Current specialist articles, state-of-the-art contributions, congress reports, expert interviews

Register now for free & stay well informed!

See also  US Calls Current Covid Vaccine Ineffective Against Omicron Subvariant BA.2, What's Next?

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.